NATIONAL PSORIASIS FOUNDATION

EIN: 930571472 501(c)(3) Diseases & Disorders

ALEXANDRIA, VA

Total Revenue
$12,648,481
Total Expenses
$11,737,962
Total Assets
$14,911,131
Net Assets
$9,961,332
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1968
Legal Domicile
VA
Principal Officer
LEAH MCCORMICK HOWARD
Phone
5032447404
Tax Period
2024-07-01 to 2025-06-30

NATIONAL PSORIASIS FOUNDATION, founded in 1968, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $12.6M in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion. Expenses of $11.7M left a modest 7% surplus.

Mission

THE NATIONAL PSORIASIS FOUNDATION PROVIDES PEOPLE WITH PSORIASIS AND PSORIATIC ARTHRITIS THE SERVICES THEY NEED TO BEST MANAGE THEIR CONDITION, WHILE PROMOTING RESEARCH TO FIND A CURE.

Program Service Accomplishments

Program 1
Expenses: $3,442,648

RESEARCHTHE NATIONAL PSORIASIS FOUNDATION (NPF) CONTINUES TO BE A LEADER IN FUNDING AND DRIVING RESEARCH TO CURE PSORIATIC DISEASE. IN FY 2025, NPF INVESTED OVER $2.5M IN RESEARCH GRANTS AND...

Read more

RESEARCHTHE NATIONAL PSORIASIS FOUNDATION (NPF) CONTINUES TO BE A LEADER IN FUNDING AND DRIVING RESEARCH TO CURE PSORIATIC DISEASE. IN FY 2025, NPF INVESTED OVER $2.5M IN RESEARCH GRANTS AND FELLOWSHIP AWARDS TOWARDS OUTSIDE-THE-BOX IDEAS AND SUPPORTED YOUNG RESEARCHERS, ENSURING PROGRESS TOWARD NOVEL TREATMENTS. THROUGH PARTNERSHIPS SUCH AS THE ACCELERATED MEDICINES PARTNERSHIP FOR AUTOIMMUNE AND IMMUNE-MEDIATED DISEASES (AMP AIM), NPF HAS WORKED WITH INDUSTRY AND NONPROFIT STAKEHOLDERS TO IDENTIFY MOLECULAR PATHWAYS AND ACCELERATE TREATMENT DEVELOPMENT. BRIDGE GRANTS HAVE ENABLED NEAR-MISS NIH RESEARCH APPLICATIONS TO SECURE ADDITIONAL DATA AND EVENTUALLY OBTAIN FEDERAL FUNDING, MULTIPLYING DONOR INVESTMENT MANY TIMES OVER. OVER THE LIFETIME OF THIS GRANT OFFERING, EVERY BRIDGE GRANT RECIPIENT SUCCESSFULLY OBTAINED FURTHER FUNDING AFTER RESUBMISSION, TURNING $1.5 MILLION IN NPF GRANTS INTO $13.5 MILLION IN FEDERAL SUPPORT. NPF COLLABORATED WITH THE GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES AND COMMUNITY ORGANIZATIONS TO EXPAND ACCESS TO DERMATOLOGIC CARE IN UNDERSERVED WASHINGTON, D.C. NEIGHBORHOODS. QUALITATIVE RESEARCH, SUCH AS THE S.T.R.A.N.D. INITIATIVE, EDUCATED HAIR STYLISTS ON RECOGNIZING SCALP CONDITIONS, BROADENING COMMUNITY AWARENESS AND EARLY DETECTION. THE NPF HEALTH CARE PROVIDER DIRECTORY WAS ENHANCED IN 2025 BY REQUIRING PROVIDERS TO ATTEST TO DELIVERING GUIDELINE-BASED, HIGH-QUALITY CARE FOCUSED ON MINIMAL DISEASE ACTIVITY AND CONTINUOUS PROFESSIONAL GROWTH.

Program 2
Expenses: $1,318,997 Revenue: $12,000

PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 26TH ANNUAL RESIDENTS AND...

Read more

PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 26TH ANNUAL RESIDENTS AND RHEUMATOLOGY FELLOWS MEETING OFFERED DERMATOLOGY RESIDENTS AND RHEUMATOLOGY FELLOWS THE LATEST IN PSORIATIC DISEASE TREATMENT PRESENTED BY EXPERTS IN THE FIELD. THROUGH ITS DEDICATION TO EDUCATING HEALTH CARE PROVIDERS ON PSORIATIC DISEASE AND ITS RELATED DISEASES, NPF HAS EARNED ACCREDITATION AS A PROVIDER OF CONTINUING MEDICAL EDUCATION. IT'S PART OF OUR EFFORTS TO ENSURE ALL DIFFERENT TYPES OF HEALTH CARE PROVIDERS UNDERSTAND THIS COMPLICATED DISEASE. NPF OFFERS THE PSOUND BYTES CONTINUING MEDICAL EDUCATION PODCASTS, WEBINARS, AND IN-PERSON CLASSES AND SEMINARS FOR A WIDE RANGE OF AUDIENCES. IN FY 2025, THE NPF CELEBRATED THE INDEXING OF THE JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS, A PEER REVIEWED OUTLET FEATURING CME ARTICLES, ALLOWING MANY MORE RESEARCHERS, CLINICIANS, AND PATIENTS TO ACCESS VALUABLE INFORMATION IN EACH ARTICLE.

Program 3
Expenses: $1,211,482

ADVOCACYNPF FURTHER AMPLIFIED ITS ADVOCACY EFFORTS. THE ORGANIZATION CONTINUES TO CHAMPION PATIENT-FRIENDLY LEGISLATION, NOTABLY THE SAFE STEP ACT, AND HAS SUPPORTED STEP THERAPY REFORMS AND COPAY...

Read more

ADVOCACYNPF FURTHER AMPLIFIED ITS ADVOCACY EFFORTS. THE ORGANIZATION CONTINUES TO CHAMPION PATIENT-FRIENDLY LEGISLATION, NOTABLY THE SAFE STEP ACT, AND HAS SUPPORTED STEP THERAPY REFORMS AND COPAY ACCUMULATOR PROTECTIONS ACROSS 40 STATES. NPF REGULARLY ADVOCATES ON CAPITOL HILL FOR BETTER CARE, ACCESS, AND FAIR PRICING. IN FY 2025, NPF PROACTIVELY EDUCATED ITS COMMUNITY ABOUT SIGNIFICANT MEDICARE CHANGES THROUGH ARTICLES, PODCASTS, AND WEBINARS, HELPING PATIENTS NAVIGATE NEW OUT-OF-POCKET MAXIMUMS AND PRESCRIPTION OPTIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $10,587,360
Program Service Revenue $2,021,113
Investment Income $721,070
Other Revenue $-681,062
TOTAL REVENUE $12,648,481

Expense Breakdown

Grants Paid $2,513,494
Salaries & Benefits $6,109,248
Fundraising Expenses $1,208,828
Program Expenses $9,233,439
Other Expenses $3,115,220
TOTAL EXPENSES $11,737,962

Year-over-Year Comparison

2024 2023 Change
Revenue $12,648,481 $11,595,768 +0.1%
Expenses $11,737,962 $12,586,852 -0.1%
Net Income $910,519 $-991,084 -1.9%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
19
Independent Members
19
Employees
57
Volunteers
624

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$689,847
Total Directors
19
$0
Key Employees
2
$566,887
Highest Compensated
4
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
CAROL OSTROW CHAIR 1.00
Officer Director
$0 $0 $0
EYAL OFIR VICE CHAIR 1.00
Officer Director
$0 $0 $0
MARY CARROLL SECRETARY 1.00
Officer Director
$0 $0 $0
BRIAN JANSSEN TREASURER 1.00
Officer Director
$0 $0 $0
ANDY BLAUVELT MD MEDICAL BOARD CHAIR 1.00
Officer Director
$0 $0 $0
RON GRAU PAST CHAIR 1.00
Officer Director
$0 $0 $0
KEN ANSIN DIRECTOR 1.00
Director
$0 $0 $0
KELLI AMERINE DIRECTOR 1.00
Director
$0 $0 $0
DIANA SANDLER MD DIRECTOR 1.00
Director
$0 $0 $0
CHRISTINE LINDSAY DIRECTOR 1.00
Director
$0 $0 $0
LARRY GREEN MD DIRECTOR 1.00
Director
$0 $0 $0
MICHAEL GRAFF DIRECTOR 1.00
Director
$0 $0 $0
ELAINE HUSNI MD DIRECTOR 1.00
Director
$0 $0 $0
VALERIE HARRISON DIRECTOR 1.00
Director
$0 $0 $0
KATHLEEN GALLANT DIRECTOR 1.00
Director
$0 $0 $0
JONATHAN SCOTT DIRECTOR 1.00
Director
$0 $0 $0
NICOLE KUBIN FROM MAY 2025 DIRECTOR 1.00
Director
$0 $0 $0
LEON KIRCIK MD FROM MAY 2025 DIRECTOR 1.00
Director
$0 $0 $0
KEITH GRAFF FROM MAY 2025 DIRECTOR 1.00
Director
$0 $0 $0
LEAH MCCORMICK HOWARD PRESIDENT/CEO 40.00
Officer
$399,224 $43,603 $442,827
RONALD GOLDSMAN CHIEF FINANCIAL OFFICER 40.00
Officer
$226,395 $20,625 $247,020
JENNIFER FAGERSTROM CHIEF REVENUE OFFICER 40.00
Key Emp
$231,654 $47,071 $278,725
GUY EAKIN CHIEF SCIENTIFC & MEDICAL OFFICER 40.00
Key Emp
$254,350 $33,812 $288,162
JASON HARRIS VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY 40.00
Highest
$158,156 $18,207 $176,363
BREANNA BAER VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS 40.00
Highest
$149,303 $24,983 $174,286
JENNIFER O'CONNOR VICE PRESIDENT OF ADVANCEMENT 40.00
Highest
$160,412 $22,921 $183,333
KATHERINE SOUTHWICK VICE PRESIDENT OF MARKETING & COMMUNICATIONS 40.00
Highest
$144,256 $17,388 $161,644
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $12,648,481 $11,737,962 $14,911,131 $910,519
2024 $11,595,768 $12,586,852 $14,679,906 $-991,084
2023 $11,591,439 $13,763,392 $13,817,026 $-2,171,953
2023 $11,591,439 $13,763,392 $13,817,026 $-2,171,953
2022 $13,390,353 $12,538,110 $13,977,875 $852,243
2021 $12,657,666 $11,129,734 $15,989,040 $1,527,932
2020 $14,236,650 $13,904,678 $14,435,005 $331,972
2019 $14,215,254 $13,425,637 $12,437,744 $789,617
Explore More Nonprofits
Top 100 Nonprofits in Virginia Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare NATIONAL PSORIASIS FOUNDATION with other nonprofits in Virginia and across the country.